The MGI Pharmacogenomics (PGX) Report provides insight into how your unique genetic profile may influence the way your body processes medications commonly used across the maternal timeline. From fertility treatments to labor medications and postpartum care, genetic variation can affect how quickly drugs are metabolized, how strongly they act in the body, and whether certain medications may be more or less effective.

This report analyzes key genes involved in drug metabolism, transport, and receptor sensitivity to help identify patterns that may influence medication response. Areas of focus may include pathways related to anesthesia response, pain management, psychiatric medications, and other drugs frequently encountered in reproductive and maternal care.

Rather than a one-size-fits-all approach to medication, the PGX Report offers a personalized lens that can support more informed discussions with healthcare providers. The goal is to help mothers and practitioners better understand potential genetic influences on medication response so that care decisions can be approached with greater precision and awareness.

The MGI PGX Report is designed to complement the broader Maternal Genomics framework, integrating pharmacogenomic insights alongside nutrition, lifestyle, and biological pathway support to create a more individualized maternal care experience.